Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Messy Rules For Non‐Biological Complex Drugs Under Fire

Executive Summary

Calls are mounting for the EU to make the centralized procedure mandatory for follow-on versions of non‐biological complex drugs and for better regulatory alignment with the US and other countries.

You may also be interested in...



Australian Reform Is Opportunity For International Work-Sharing On Non-Biological Complex Drugs

Plans to streamline the approval of generic medicines in Australia must include measures to ensure that safe and effective similar versions of non-biological complex medicines are available.

Australian Generics Approval Reform Is Opportunity For International Work-Sharing On Non-Biological Complex Drugs

Plans to streamline the approval of generic medicines in Australia must include measures to ensure that safe and effective similar versions of non-biological complex medicines are available.

Faster Please: Alnylam, Eiger & BioCryst Want Quick EMA Reviews

Three companies are set to learn this week whether the European Medicines Agency will fast track its review of their soon-to-be-filed EU marketing applications.

Topics

Related Companies

UsernamePublicRestriction

Register

PS125471

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel